Prognostic Significance of Nutritional Scores in Patients With Heart Failure: Insights From the PARAGON‐HF Trial
Authors:
- Henri LuHLHenri Lu
- Brian L. ClaggettBCBrian L. Claggett
- John W. OstrominskiJOJohn W. Ostrominski
- Alberto FoàAFAlberto Foà
- Maria A. PabónMPMaria A. Pabón
- Arzu KalayciAKArzu Kalayci
- Muthiah VaduganathanMVMuthiah Vaduganathan
- Maja CikesMCMaja Cikes
- Amil M. ShahASAmil M. Shah
- Akshay S. DesaiADAkshay S. Desai
- John J. V. McMurrayJMJohn J. V. McMurray
Open Access
- 6 May 2025
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 14 (9) , e038872
Abstract
Background: The Controlling Nutritional Status (CONUT) and Geriatric Nutritional Risk Index (GNRI) are indices that identify individuals at risk of malnutrition. Our study sought to examine the incidence and prognostic implications of abnormal CONUT and/or GNRI in patients with heart failure with preserved ejection fraction. Methods and Results: The CONUT score and GNRI were serially analyzed in this post hoc analysis of the PARAGON‐HF (Prospective Comparison of Angiotensin Receptor–Neprilysin Inhibitor With Angiotensin‐Receptor Blockers Global Outcomes in Heart Failure With Preserved Ejection Fraction) trial. A CONUT score >2 or GNRI ≤98 was considered to be abnormal. The association between abnormal CONUT and/or GNRI (analyzed using a time‐updated approach) and total heart failure hospitalizations and cardiovascular death was analyzed. Other outcomes included cardiovascular death, all‐cause death, total heart failure hospitalizations, first all‐cause hospitalization, and first noncardiovascular hospitalization. We also explored the effect of incident hospitalization on subsequent incident abnormal CONUT and/or GNRI. In 4794 patients (55% women, mean age 72±8 years), 1119 (23.3%) had at least 1 abnormal score at randomization. Among the remaining 3675 patients, 1405 (38.2%) developed at least 1 abnormal score over a median follow‐up of 2.9 years. Any abnormal score during follow‐up was associated with a significantly higher risk of fatal and nonfatal outcomes, and all types of hospitalizations (all‐cause, heart failure, and noncardiovascular hospitalizations). Among patients with normal scores at randomization, any hospitalization during follow‐up was associated with a significantly higher risk of developing at least 1 abnormal score posthospitalization, compared with prehospitalization and never‐hospitalized patients (adjusted hazard ratio, 1.37 [95% CI, 1.22–1.55]). Conclusions: Among patients with heart failure with preserved ejection fraction, the rate of individuals with abnormal CONUT and/or GNRI was high, especially following a heart failure hospitalization, and was linked with excess cardiovascular and noncardiovascular events. Registration: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT01920711.Keywords
This publication has 29 references indexed in Scilit:
- Heart Failure With Preserved Ejection FractionJACC, 2023
- Nutrition Assessment and Dietary Interventions in Heart FailureJACC, 2022
- Prevalence and Prognostic Significance of Malnutrition in Patients With Acute Coronary SyndromeJACC, 2020
- During Hospitalization, Older Patients at Risk for Malnutrition Consume <0.65 Grams of Protein per Kilogram Body Weight per DayNutrition in Clinical Practice, 2020
- Nutrition, Obesity, and Cachexia in Patients With Heart Failure: A Consensus Statement from the Heart Failure Society of America Scientific Statements CommitteeJournal of Cardiac Failure, 2019
- GLIM criteria for the diagnosis of malnutrition – A consensus report from the global clinical nutrition communityClinical Nutrition, 2019
- Controlling Nutritional Status (CONUT) score is a prognostic marker for gastric cancer patients after curative resectionGastric Cancer, 2017
- ESPEN guidelines on definitions and terminology of clinical nutritionClinical Nutrition, 2017
- Review of nutritional screening and assessment tools and clinical outcomes in heart failureHeart Failure Reviews, 2016
- Human Serum Albumin in the Clinical Syndrome of Heart FailureJournal of Cardiac Failure, 2011